ライフサイエンスコーパス: antigen-presenting cell

1 ls (DCs) are the most effective professional antigen-presenting cell.

2 identified plasmacytoid DCs as an important antigen-presenting cell.

3 r (TCR) for peptide-loaded MHCs (pMHC) on an antigen-presenting cell.

4 curs at the junction between a T cell and an antigen-presenting cell.

5 the cortical cytoskeleton of the interacting antigen-presenting cell.

6 rimed with their cognate determinants by the antigen presenting cells.

7 beta-cells, and human MHC-II is expressed on antigen presenting cells.

8 nflammatory cytokines and act as more potent antigen presenting cells.

9 ent on the plasma membrane of thymocytes and antigen presenting cells.

10 ide creates glycopeptides in the endosome of antigen-presenting cells.

11 ter of the interface of T cells activated by antigen-presenting cells.

12 imilar to dermal cDC2 but are more efficient antigen-presenting cells.

13 ent renal macrophages to act as professional antigen-presenting cells.

14 It is upregulated on activated antigen-presenting cells.

15 s that initiate GVHD, including the relevant antigen-presenting cells.

16 80 by dendritic cells (DCs) but not by other antigen-presenting cells.

17 stiffness comparable to that of professional antigen-presenting cells.

18 essing and presentation as a self-antigen by antigen-presenting cells.

19 esponses once the bioconjugate is uptaken by antigen-presenting cells.

20 memory-like CD4(+) T cells colocalized with antigen-presenting cells.

21 enes in response to IFN gamma and may act as antigen-presenting cells.

22 nomodulatory effect of the L. kefiri SLPs on antigen-presenting cells.

23 s with human monocyte-derived macrophages as antigen-presenting cells.

24 ted lipid that is required for activation of antigen-presenting cells.

25 rvous system, where they are restimulated by antigen-presenting cells.

26 hils, eosinophils, T cells, and professional antigen-presenting cells.

27 of tumor-associated antigens on surrounding antigen-presenting cells.

28 plex class I (p-MHC I) proteins displayed by antigen-presenting cells.

29 omplex molecules expressed on the surface of antigen-presenting cells.

30 o changes in protein expression within these antigen-presenting cells.

31 rlay an arrangement of B cells, T cells, and antigen-presenting cells.

32 nd blocks IgE binding to CD23 on B cells and antigen-presenting cells.

33 d CD8(+) T cell activation when expressed on antigen-presenting cells.

34 ligently assess the ability of MCs to act as antigen-presenting cells.

35 antigens presented by MHC-family proteins on antigen-presenting cells.

36 RP150; and increased exosomal stimulation of antigen-presenting cells.

37 surveillance, T cells survey the surface of antigen-presenting cells.

38 sues and are related to adult populations of antigen-presenting cells.

39 of dendritic cells to fulfill their role as antigen-presenting cells.

40 istocompatibility complex (MHC) molecules on antigen-presenting cells.

41 Cs in comparison with functionally competent antigen-presenting cells.

42 histocompatibility complex II expression by antigen-presenting cells.

43 to represent the surface of HIV Env-bearing antigen-presenting cells.

44 ajor histocompatibility complex molecules on antigen-presenting cells.

45 toid dendritic cells (pDCs) are professional antigen-presenting cells.

46 d by neutrophils, T(H)17 cells, B cells, and antigen-presenting cells.

47 or of CD4-positive lymphocytes and MHC II on antigen-presenting cells.

48 emselves, are abundant on B cells and thymic antigen-presenting cells.

49 sing CD4(+) T helper cells and maturation of antigen-presenting cells.

50 ibodies facilitating uptake of immunogens by antigen-presenting cells.

51 mination of antigen uptake and processing by antigen-presenting cells.

52 te T cells without the need for professional antigen-presenting cells.

53 tissues, whereas the latter is restricted to antigen-presenting cells.

54 The production and wide use of artificial antigen presenting cells (aAPCs) in the clinic as cancer

55 of Mtb protein-coding genes using artificial antigen-presenting cells (aAPCs) and reporter T cells.

56 ducing Tregs, B cell antibody production and antigen-presenting cell activity is a target of Treg sup

57 udy, we report that these highly stimulatory antigen-presenting cells also express enhanced levels of

58 g to cognate peptide-MHC complexes (pMHC) on antigen presenting cells and by bringing p56(Lck) to TCR

59 pacts the activation and maturation of fetal antigen presenting cells and innate lymphocytes, which c

60 major histocompatibility complex class II on antigen-presenting cells and activate T cells through T

61 CD40 agonists bind the CD40 molecule on antigen-presenting cells and activate them to prime tumo

62 erial protein that is naturally processed by antigen-presenting cells and activated gliadin reactive

63 Innate antigen-presenting cells and adaptive immune T cells hav

64 e a heterogeneous population of professional antigen-presenting cells and are key cells of the immune

65 while retaining their ability to function as antigen-presenting cells and by actively suppressing de

66 The ligand for 4-1BB is expressed on antigen-presenting cells and EBV-transformed B cells.

67 us on how Mycobacterium tuberculosis infects antigen-presenting cells and evades effective immune cle

68 erm-free mice was seeded with low numbers of antigen-presenting cells and impaired chemokine and alar

69 and adjuvants can promote their delivery to antigen-presenting cells and improve immunogenicity.

70 gastrointestinal lipids, and trafficking of antigen-presenting cells and lymphocytes to lymphoid org

71 that plasma cells in the gut can function as antigen-presenting cells and might promote and maintain

72 t MVA-B13R significantly delays apoptosis in antigen-presenting cells and muscle cells in vitro and a

73 However, many phagocytic cells also act as antigen-presenting cells and must balance degradation an

74 Cytokine production by antigen-presenting cells and other innate cells influenc

75 T cells must migrate to encounter antigen-presenting cells and perform their roles in host

76 ested on a mixed lymphocyte reaction between antigen-presenting cells and recipient T cells.

77 ein blocking costimulatory signaling between antigen-presenting cells and T cells through CD28.

78 exogenous vaccination, to the engineering of antigen-presenting cells and T cells, and to the modulat

79 -encoded FSP was processed in vitro by human antigen-presenting cells and was subsequently able to ac

80 ritic cells (moDCs) that represent classical antigen-presenting cells and we aimed at studying IgE-de

81 concentrating in one location the antigens, antigen-presenting cells, and antigen-responsive lymphoc

82 l-mediated transport and serve as artificial antigen-presenting cells, and iii) macroscale materials

83 n to induce activation of endothelial cells, antigen-presenting cells, and platelets, resulting in a

84 )2 cells, group 2 innate lymphoid cells, and antigen-presenting cells; and T3 CRSsNP was associated w

85 mal cellular compartment of BMDCs, increases antigen presenting cell (APC) trafficking to draining ly

86 the center of the T cell interface with the antigen presenting cell (APC).

87 es is classically thought to depend on their antigen-presenting cell (APC) activity.

88 that curcumin nanoparticles enhance various antigen-presenting cell (APC) functions, including autop

89 The engagement of a T cell with an antigen-presenting cell (APC) or activating surface resu

90 coordinated interactions of T cells with two antigen-presenting cell (APC) populations, B cells and d

91 nce, but the relative contributions of these antigen-presenting cell (APC) subsets remain unresolved.

92 co-stimulation and B7 expression by specific antigen-presenting cell (APC) types are required for clo

93 addition to antigen and to identify the lung antigen-presenting cell (APC) types that sustain the sel

94 eptor that mediates stable interactions with antigen-presenting cell (APC), as well as chemokine-medi

95 ells encounter antigens on the surface of an antigen-presenting cell (APC), B cell receptors (BCRs) a

96 esponse to specific infections or neoplasms, antigen-presenting cells (APC) and effector T cells form

97 The interaction of antigen-presenting cells (APC) with sensitized helper T

98 ntermittent C, CI, and vinorelbine activates antigen-presenting cells (APC), and abrogates local and

99 s on the robust activation of tumor-specific antigen-presenting cells (APC).

100 instead transfer their antigens to CD11c(+) antigen-presenting cells (APC).

101 with prominent infiltration of the skin with antigen presenting cells (APCs) and T cells.

102 l as tumor-specific peptide neoantigens into antigen presenting cells (APCs) in lymph nodes for cance

103 Tumour cell phagocytosis by antigen presenting cells (APCs) is critical to the gener

104 cle-immunotherapy system targeting pulmonary antigen presenting cells (APCs) to enhance anticancer im

105 res antigens to be exposed on the surface of antigen presenting cells (APCs) via MHC class II (MHC-II

106 lantation, the "cross-dressing" of recipient antigen presenting cells (APCs) with intact donor major

107 The abundance of immunocompetent antigen presenting cells (APCs) within the skin makes th

108 cies of CD45(+) leukocytes, CD11b(+)MHCII(+) antigen presenting cells (APCs), CD4(+)IFN-gamma(+) effe

109 established between breast cancer cells and antigen presenting cells (APCs), CTLA-4 expressed on the

110 o the endosomal compartments of professional antigen presenting cells (APCs).

111 related with reduced type I IFN signaling in antigen-presenting cells (APCs) and decreased priming of

112 itiated by the interaction between recipient antigen-presenting cells (APCs) and donor T cells, culmi

113 gen recognition receptor function in primary antigen-presenting cells (APCs) and fibroblasts were per

114 n Vgamma9Vdelta2 T cells can act in vitro as antigen-presenting cells (APCs) and induce alphabeta T-c

115 t AC-NPs deliver tumour-specific proteins to antigen-presenting cells (APCs) and significantly improv

116 supporting a role for B cells functioning as antigen-presenting cells (APCs) and/or regulatory cells

117 Although antigen-presenting cells (APCs) are required for antigen

118 Synthetic antigen-presenting cells (APCs) are used to mediate scal

119 cular pathways behind PD-L1 up-regulation on antigen-presenting cells (APCs) by BCG.

120 ng network's ability to discriminate between antigen-presenting cells (APCs) displaying either self l

121 of donor T cell reactivity elicited by host antigen-presenting cells (APCs) expressing MHC-encoded m

122 ecifically recruited to sites with activated antigen-presenting cells (APCs) in a CXCR3-dependent man

123 ucing an interaction between CAR T cells and antigen-presenting cells (APCs) in lymphoid tissue, away

124 Professional antigen-presenting cells (APCs) in the skin include dend

125 gh oxidative stress, and present them to the antigen-presenting cells (APCs) in the spleen.

126 on incapacitates PRRSV-susceptible CD14(pos) antigen-presenting cells (APCs) in the thymus and throug

127 1891, targets STING-activation to phagocytic antigen-presenting cells (APCs) in the tumor and activat

128 Comparatively, the majority of antigen-presenting cells (APCs) in tissue in acute GVHD

129 Antigen-presenting cells (APCs) including dendritic cell

130 Activation of naive T cells by antigen-presenting cells (APCs) is an essential step in

131 ribution of CD1d molecules on the surface of antigen-presenting cells (APCs) modulates activation of

132 Antigen-presenting cells (APCs) mounted weaker responses

133 Antigen-presenting cells (APCs) occupy diverse anatomica

134 Antigen-presenting cells (APCs) play an important role i

135 Furthermore, PD-L1 expression on antigen-presenting cells (APCs) prevented CTLA-4-mediate

136 I presentation was dominated by professional antigen-presenting cells (APCs) rather than cancer cells

137 sentinels, but whether they also function as antigen-presenting cells (APCs) remains elusive.

138 Together, these danger signals activate antigen-presenting cells (APCs) to efficiently present a

139 y isolated human neutrophils can function as antigen-presenting cells (APCs) to memory CD4(+) T cells

140 The percentages of B cells and antigen-presenting cells (APCs) were much higher in the

141 endogenous Treg and Th17 cells together with antigen-presenting cells (APCs) within the spinal cord l

142 receptors (TLR) 7/8 are potent activators of antigen-presenting cells (APCs), however, they also indu

143 or binding to and infection of primary human antigen-presenting cells (APCs), including monocytes, ma

144 e to autoimmunity by serving as professional antigen-presenting cells (APCs), producing cytokines, an

145 recipients, only hematopoietic, not stromal, antigen-presenting cells (APCs), provided such stimulati

146 When migratory T cells encounter antigen-presenting cells (APCs), they arrest and form ra

147 ocompatibility complex proteins expressed by antigen-presenting cells (APCs), very fast receptor trig

148 onocyte-derived cells (MCs) become competent antigen-presenting cells (APCs).

149 at promotes viral dissemination by hijacking antigen-presenting cells (APCs).

150 ched with dysfunctional and immunosuppressed antigen-presenting cells (APCs).

151 ve been proposed to convert neutrophils into antigen-presenting cells (APCs).

152 e peptides bound to MHC molecules (pMHCs) on antigen-presenting cells (APCs).

153 ry T (Treg) cells by multiple mechanisms via antigen-presenting cells (APCs).

154 ng vaccine delivery system (PMVDS) to target antigen-presenting-cells (APCs) such as dendritic cells.

155 On the basis that donor bone marrow-derived antigen-presenting cells are eliminated within days of t

156 hat isolevuglandin-modified self-proteins in antigen-presenting cells are immunogenic, promoting cyto

157 e autoreactive CD4(+) T cells and B cells as antigen-presenting cells are involved in MS pathogenesis

158 apsid-specific CD8(+) T cells, whereas other antigen-presenting cells are not involved.

159 through immunofluorescence that professional antigen-presenting cells are the primary cells containin

160 rn recognition receptors (PRRs) expressed in antigen-presenting cells are thought to shape pathogen-s

161 tent anti-inflammatory capacities in primary antigen presenting cells as well as T cells.

162 (DED) through its role in the maturation of antigen-presenting cells at the ocular surface after exp

163 To acquire antigens displayed by antigen-presenting cells, B cells form immune synapses a

164 ome controls interleukin-1beta maturation in antigen-presenting cells, but a direct role for NLRP3 in

165 herapy via the skin targets a tissue rich in antigen-presenting cells, but can be associated with loc

166 ce abundant DNA fragments for DNA sensing in antigen-presenting cells, but the intrinsic DNA sensing

167 Here we show that subsets of antigen-presenting cells can be identified in fetal tiss

168 roblast-like synoviocytes to endow them with antigen-presenting cell capabilities and an inflammatory

169 min production, and seeding of the skin with antigen-presenting cells capable of instructing recruite

170 d plasma levels of pentraxin-2 and activated antigen-presenting cells, CD4 and CD8 T cells, and Th17-

171 ler cells), and interleukin 12 production by antigen-presenting cells compared with single-agent anti

172 Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation.

173 thway in nonprofessional versus professional antigen-presenting cells could influence morbidity and m

174 Upon contact with antigen-presenting cells, cytotoxic T lymphocytes (T cel

175 e 2019;25:565-577.e6) define the liver-based antigen-presenting cell driving CD8 T cell responses to

176 played superior antitumor efficacy, licensed antigen-presenting cells, enhanced recruitment of immune

177 ncreases checkpoint inhibition by activating antigen-presenting cells, enhancing intratumoral Tcf1(+)

178 r dependent on the EPO receptor and CD131 on antigen-presenting cells, EPO induced the secretion of a

179 Dendritic cells (DCs) are efficient antigen-presenting cells equipped with various cell surf

180 We found that B cells serve as potent antigen-presenting cells ex vivo and restimulate in vivo

181 While DCs are the major antigen presenting cells for cross-presenting tumor anti

182 ngeable peptide/HLA multimers and artificial antigen-presenting cells for 25 different class I allele

183 rentiation of monocytes into tissue-resident antigen-presenting cells for activation of antiviral T c

184 lls use microvilli to search the surfaces of antigen-presenting cells for antigenic ligands.

185 Arachis hypogaea, Ara h 1 and 2, and used as antigen-presenting cells for autologous CD4(+) T cells (

186 understand more about the role of B cells as antigen-presenting cells for CD4(+) T cell with indirect

187 production of antibodies and functioning as antigen-presenting cells for CD4+ and CD8+ T cells.

188 microparticles (MPs) which passively target antigen-presenting cells for intracellular release.

189 that B cells contribute to late rejection as antigen-presenting cells for intragraft memory T cell ex

190 tain epitope specificities could be the main antigen-presenting cells for pathogenic, gluten-specific

191 When a T cell and an antigen-presenting cell form an immunological synapse, r

192 Pulsing of antigen-presenting cells from HLA-DRB1*11- and HLA-DRB1*

193 filarial infection, including suppression of antigen-presenting cell function and downmodulation of f

194 the pathogenesis of PFAPA involves abnormal antigen-presenting cell function and T cell activity and

195 of the CD47-SIRPalpha axis may also promote antigen-presenting cell function and thereby stimulate a

196 mine whether IFN-alpha exposure alters human antigen-presenting cell function in vivo.

197 r cognate ligands are critical for enhancing antigen-presenting cell functions and influencing T cell

198 be the mechanical properties of the opposing antigen-presenting cell, giving rise to different signal

199 Antigen-presenting cells had low HLA-DR and CD86 express

200 tor on lymphocytes and its ligand (PD-L1) on antigen-presenting cells have been well studied in tumor

201 es can bridge an immune effector cell and an antigen-presenting cell, implying that mechanical forces

202 nting the numbers and functional capacity of antigen presenting cells in the lungs of diabetic mice.

203 to 300nm diameter, and induced maturation of antigen presenting cells in vitro.

204 ce of inflammation to become tissue-resident antigen presenting cells in vivo.

205 ariety of human monocyte-derived tolerogenic antigen-presenting cells in current development as cell-

206 ent cytosolic delivery of tumour antigens to antigen-presenting cells in draining lymph nodes, leadin

207 be accounted for by greater RBD uptake into antigen-presenting cells in particulate form and improve

208 thma, we investigated the role of B cells as antigen-presenting cells in priming and maintenance of T

209 epidermal tumors by regulating the number of antigen-presenting cells in skin.

210 The reduced presence of antigen-presenting cells in the absence of MIF was assoc

211 e found that MIF both recruits and maintains antigen-presenting cells in the dermis/epidermis.

212 responses were intact when DCs were used as antigen-presenting cells in the presence of IL-21, but I

213 y delays MVA-induced apoptosis in muscle and antigen-presenting cells in vitro and augments vaccine-i

214 vate pattern recognition receptors (PRRs) on antigen-presenting cells, including monocytes and macrop

215 samine or N-acetylglucosamine target hepatic antigen-presenting cells, increase their antigen present

216 gradient created from stromal, lymphoid, or antigen presenting cell interactions.

217 nfection and highlights the heterogeneity of antigen-presenting cells involved in CD4+ T cell priming

218 ly immunogenic peptides presented by MHCs of antigen presenting cells is one of the most important me

219 gate whether the number of CD23 molecules on antigen-presenting cells is associated with IgE levels a

220 ed adhesion between alloreactive T cells and antigen-presenting cells is essential for allorejection.

221 n most cases, the contribution of B cells as antigen-presenting cells is not well understood.

222 gh MHC II is mainly produced by professional antigen-presenting cells, it can be aberrantly produced

223 ealed statistically significant increases in antigen presenting cell:leukocyte pairings, Foxp3+CD4+ T

224 ealed statistically significant increases in antigen-presenting cell:leukocyte pairings, FOXP3(+) /CD

225 n placental hormones, remained viable within antigen presenting cells, limited inflammation ex vivo a

226 bridomas, interrogated their reactivities to antigen-presenting cell lines.

227 ation of GI-resident CD4(+) T cells, loss of antigen-presenting cells, loss of innate lymphocytes, an

228 These formulations induce antigen-presenting cell maturation via the intracellular

229 eads to TH2 sensitization and to study which antigen-presenting cells mediate this process.

230 lycosylated autoantigens targeted to hepatic antigen-presenting cells might enable therapies that pro

231 Finally, mechanical properties of adherent antigen-presenting cells modulate cytokine production by

232 that these stem-like T cells reside in dense antigen-presenting-cell niches within the tumour, and th

233 The immune system relies on antigen-presenting cells of the innate immune system to

234 ar to LCs but does not appear to function as antigen-presenting cells or acts as HIV target cells.

235 hagocytose particles and act as professional antigen-presenting cells (pAPC).

236 Intestinal professional antigen presenting cells (pAPCs) recognize and respond t

237 Similarly, in professional antigen-presenting cells, peptides from minute amounts o

238 ration of dendritic cells, and chemotaxis of antigen-presenting cells pointing to an impaired migrato

239 tibility complex class II (MHC)-II(+) mature antigen-presenting cell population kinetics during infla

240 th induction of immunological effects on the antigen-presenting cell populations.

241 s II glycoproteins, expressed by specialized antigen-presenting cells, present peptides to alphabeta

242 ught to be orchestrated by T cells primed by antigen-presenting cell presenting alloantigens.

243 g HLA-B*57:01 binding and peptide display by antigen presenting cells relate to the activation of CD8

244 nds present on the surface of the T cell and antigen-presenting cell, respectively.

245 will continue to unravel how epithelial and antigen-presenting cells respond to AdVs and control inf

246 Understanding how professional antigen-presenting cells respond to immunomodulation is

247 Infection of antigen-presenting cells results in SPI-2 T3SS-dependent

248 Codelivery of antigen and adjuvant to antigen-presenting cells results in: 1) initial short-li

249 f the genes associated with monocyte-derived antigen presenting cells revealed differences between RM

250 leads to increased innate immune responses, antigen-presenting cell stimulation, and priming of over

251 Dendritic cells (DCs) are antigen-presenting cells subdivided in specialized subse

252 riers transferring antigen to more efficient antigen-presenting cells such as DCs.

253 immune organ comprised of a large network of antigen-presenting cells such as dendritic cells, making

254 lycan-recognizing innate immune receptors on antigen-presenting cells, such as the C-type lectin immu

255 uniquely able to boost populations of potent antigen-presenting cells, such as tumor-infiltrating neu

256 Tolar explore how the physical properties of antigen-presenting cell surfaces affect how B cells inte

257 overed IL-6/IL-6R transpresentation in which antigen-presenting cells synthesize and express IL-6/IL-

258 T(H)1 and CD8(+)), natural killer cells, and antigen-presenting cells; T2 CRSsNP was associated with

259 the cancer cells can act as tumor-associated antigen-presenting cells (tAPCs) by inducing coexpressio

260 adapted this approach to alpha-syn using the antigen-presenting cell-targeting glucan microparticle (

261 at a novel vaccination modality combining an antigen-presenting cell-targeting glucan particle (GP) v

262 infection, dendritic cells (DC) mature into antigen-presenting cells that activate T cells, linking

263 ional dendritic cells (cDC) are professional antigen-presenting cells that induce immune activation o

264 Dendritic cells (DC) are professional antigen-presenting cells that orchestrate immune respons

265 which increased uptake by and activation of antigen-presenting cells that promote T-cell immunity.

266 angerhans cells (LCs) are epidermis-resident antigen-presenting cells that share a common ontogeny wi

267 ll polarizing cytokines or induce inhibitory antigen-presenting cells that suppress T-cell activation

268 cted THP-1 monocytes, which are professional antigen-presenting cells, the reductions in NLRC5 and MH

269 to lymph nodes and decorated the surfaces of antigen-presenting cells, thereby priming CAR-Ts in the

270 tely, whereas some progeny are terminated in antigen-presenting cells, thereby stimulating immunity.

271 mant naive T cells first become activated by antigen-presenting cells, they express the autocrine gro

272 fferentiation of specific T cell subsets and antigen-presenting cells, thought to be relevant in the

273 CD6 facilitates adhesion between T cells and antigen-presenting cells through its interaction with CD

274 HCII) molecules from the surface of infected antigen-presenting cells through ubiquitination of the c

275 regulate T cells and change the phenotype of antigen presenting cells to efficiently induce IL-10(+)

276 e binding of peptide-loaded MHC (pMHC) on an antigen-presenting cell to the T cell receptor (TCR) on

277 immune response, facilitating trafficking of antigen-presenting cells to draining lymph nodes.

278 ered T cells generate forceful contacts with antigen-presenting cells to improve access to antigen.

279 unological players from epithelial cells and antigen-presenting cells to innate lymphoid cells and re

280 AX- and Clav-specific clones required antigen-presenting cells to proliferate, and drugs were

281 the Y. pseudotuberculosis-CD209 interaction antigen-presenting cells to reach their target destinati

282 pacity of the fetal immune system, including antigen-presenting cells, to detect and respond to such

283 s that coordinate Treg cell development, the antigen-presenting cell types that direct Treg cell sele

284 re, whereupon they can transform into potent antigen-presenting cells upon full maturation.

285 rs tumor antigens to human CD169/Siglec-1(+) antigen-presenting cells using gangliosides as targeting

286 n of the activity of effector T cells and of antigen presenting cells via upregulation of suppressive

287 Costimulation induced on microbe-infected antigen presenting cells was able to overcome cAMP-media

288 and adjuvant from implanted vaccine films by antigen-presenting cells was demonstrated using in vivo

289 rs further established that the frequency of antigen-presenting cells was limited compared to benign

290 Uptake of these nanoparticles by antigen-presenting cells was shown to induce immune tole

291 through a genome-wide mutant screen of human antigen-presenting cells, we show that the NEDD4 family

292 HLA class II alleles encode MHC proteins on antigen-presenting cells, which function to present pept

293 O induced the secretion of active TGFbeta by antigen-presenting cells, which in turn converted naive

294 Homeostatic antigen presentation by hepatic antigen-presenting cells, which results in tolerogenic T

295 ting recruitment of effector lymphocytes and antigen-presenting cells, while reducing immunosuppressi

296 the health of cells, the immune system tasks antigen-presenting cells with gathering antigens from ot

297 chestration of antigen cross-presentation in antigen-presenting cells with innate stimulation.

298 chestration of antigen cross-presentation in antigen-presenting cells with innate stimulation.

299 lls (DCs) are a diverse group of specialized antigen-presenting cells with key roles in the initiatio

300 The encounter of antigen-presenting cells with T lymphocytes in secondary